Pure Global
NCT05998785

Embody Insertional Achilles Tendinopathy

A Multi-Center, Prospective Case Series Evaluating Insertional Achilles Tendinopathy Repair Augmented With TAPESTRY® Biointegrative Implant
Zimmer Biomet·ClinicalTrials.gov·device·Device trialEnrolling by invitation
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Insertional Achilles Tendinopathy
Drug/Device/Intervention
TAPESTRY Biointegrative Implant
Study type
Observational
Intervention type
device
Sponsor & location
Primary sponsor
Zimmer Biomet
Location
Libertyville,Tulsa, United States of America
Timeline & enrollment
Phase
N/A
Start date
Aug 02, 2022
End date
Dec 01, 2024
Enrollment
15 participants
Primary outcome

Pain/VAS

Summary

The primary objective of this study is to evaluate the long-term effects on ankle/Achilles
 tendon pain after repair of insertional Achilles tendinopathy (IAT) augmented with TAPESTRY
 Biointegrative Implant.

ICD-10 classifications
Achilles tendinitisInjury of Achilles tendonShort Achilles tendon (acquired)Spontaneous rupture of unspecified tendonInjury of unspecified muscle and tendon at ankle and foot level
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT05998785
Type
Device Trial
About this record

Access comprehensive clinical trial information for NCT05998785 through Pure Global AI's free database. This phase not specified trial is sponsored by Zimmer Biomet and is currently Enrolling by invitation. The study focuses on Insertional Achilles Tendinopathy. Target enrollment is 15 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.